"Designing Growth Strategies is in our DNA"
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Prevalence of Sudden Cardiac Arrest- Key Countries
4.2 Technological Developments in Implantable Defibrillators
4.3 Key Mergers and Acquisitions
5. Global Implantable Cardioverter Defibrillator (ICD) Market Analysis, Insights and Forecast,2015-2026
5.1. Key Findings / Summary
5.2 Market Analysis, Insights and Forecast – By Product Type
5.2.1 Transveneous ICD
5.2.1.1 Single Chamber ICD
5.2.1.2 Dual Chamber ICD
5.2.1.3 CRT-D(Cardiac Resynchronization Therapy- Defibrillator)
5.2.2 Subcutaneous ICD
5.3. Market Analysis, Insights and Forecast – By End User
5.3.1 Clinics and Hospitals
5.3.2 Ambulatory Surgery Centers and Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1 North America
5.4.2 Europe
5.4.3 Asia Pacific
5.4.4 Rest of the World
6. North America Implantable Cardioverter Defibrillator (ICD) Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Product Type
6.2.1 Transveneous ICD
6.2.1.1 Single Chamber ICD
6.2.1.2 Dual Chamber ICD
6.2.1.3 CRT-D(Cardiac Resynchronization Therapy- Defibrillator)
6.2.2 Subcutaneous ICD
6.3. Market Analysis, Insights and Forecast – By End User
6.3.1 Clinics and Hospitals
6.3.2 Ambulatory Surgery Centers and Others
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1 U.S.
6.4.2 Canada
7. Europe Implantable Cardioverter Defibrillator (ICD) Market Analysis, Insights and Forecast,2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Product Type
7.2.1 Transveneous ICD
7.2.1.1 Single Chamber ICD
7.2.1.2 Dual Chamber ICD
7.2.1.3 CRT-D(Cardiac Resynchronization Therapy- Defibrillator)
7.2.2 Subcutaneous ICD
7.3. Market Analysis, Insights and Forecast – By End User
7.3.1 Clinics and Hospitals
7.3.2 Ambulatory Surgery Centers and Others
7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
7.4.1 U.K.
7.4.2 Germany
7.4.3 France
7.4.4 Italy
7.4.5 Spain
7.4.6 Scandinavia
7.4.7 Rest of Europe
8. Asia Pacific Implantable Cardioverter Defibrillator (ICD) Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Product Type
8.2.1 Transveneous ICD
8.2.1.1 Single Chamber ICD
8.2.1.2 Dual Chamber ICD
8.2.1.3 CRT-D(Cardiac Resynchronization Therapy- Defibrillator)
8.2.2 Subcutaneous ICD
8.3. Market Analysis, Insights and Forecast – By End User
8.3.1 Clinics and Hospitals
8.3.2 Ambulatory Surgery Centers and Others
8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 Australia
8.4.5 South East Asia
8.4.6 Rest ofAsia Pacific
9. Rest of the World Implantable Cardioverter Defibrillator (ICD) Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Product Type
9.2.1 Transveneous ICD
9.2.1.1 Single Chamber ICD
9.2.1.2 Dual Chamber ICD
9.2.1.3 CRT-D(Cardiac Resynchronization Therapy- Defibrillator)
9.2.2 Subcutaneous ICD
9.3. Market Analysis, Insights and Forecast – By End User
9.3.1 Clinics and Hospitals
9.3.2 Ambulatory Surgery Centers and Others
10. Competitive Analysis
10.1. Key Industry Developments
10.2. Global Market Share Analysis (2018)
10.3. Comparative Analysis –Major Players
10.4. Company Profiles (Overview,Products & Services, SWOT Analysis, Recent Developments, Strategies,Financials (Based on Availability))
10.4.1 Boston Scientific Corporation
10.4.2 Biotronik
10.4.3 Medtronic
10.4.4 LivaNova PLC
10.4.5 Abbott
10.4.6 MicroPort
10.4.7 Other Prominent Players
11. Strategic Recommendations
Related Reports